2680eP Metastatic fumarate hydratase-deficient renal cell carcinoma (FHRCC): outcome on first-line immune checkpoint inhibitor (ICI) combination: a multicenter retrospective study (FUMAHRE study). - Guida, A.; Bimbatti, D.; Di Marco, A.; Calabrese, M.; Beuselinck, B.; Ciccarese, C.; Quattrocchi, A.M.O.; Messina, C.; Conteduca, V.; Stellato, M.; Maiorano, B.A.; Mammone, G.; et al. (Annals of Oncology, 2025)